World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
15318
World Ranking
3006
National Ranking
201

Thorsten Wolff publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thorsten Wolff sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 186 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thorsten Wolff D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thorsten Wolff sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thorsten Wolff is affiliated with the Robert Koch Institute in Germany. Their research primarily focuses on the field of Medicine, with a strong emphasis on Epidemiology and Infectious Diseases. Additional subfields include Molecular Biology, Immunology, and Pulmonary and Respiratory Medicine.

The main topics covered in Wolff's work involve Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, and Respiratory viral infections research. Other areas of study include SARS-CoV-2 detection and testing, interferon and immune responses, Viral gastroenteritis research and epidemiology, as well as RNA and protein synthesis mechanisms.

Wolff has published multiple research articles in various journals. Some recent papers include:

  • SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis, 2021, Cell
  • Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch, 2021, Wellcome Open Research
  • Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2, 2021, Wellcome Open Research
  • Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data, 2021, The Lancet Regional Health - Europe
  • Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry, 2020, Nature Nanotechnology

Frequent coauthors in Wolff's research include Ralf Dürrwald, Christin Mache, Andreas C. Hocke, Christian Drosten, and Barbara Biere.

Common publication venues for Wolff's work are:

  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Research Square (Research Square)
  • Eurosurveillance
  • Journal of Clinical Microbiology

Best Publications

  • Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication

    Alexander Karlas;Nikolaus MacHuy;Yujin Shin;Klaus Peter Pleissner

  • The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host

    G. Gabriel;B. Dauber;T. Wolff;Oliver Planz

  • IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses.

    Deborah J. Lenschow;Caroline Lai;Natalia Frias-Staheli;Nadia V. Giannakopoulos

  • Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

    Stephan Pleschka;Thorsten Wolff;Christina Ehrhardt;Gerd Hobom

  • SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis

    Daniel Wendisch;Oliver Dietrich;Tommaso Mari;Saskia von Stillfried

  • Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

    Victor Corman;Marcel Müller;U. Costabel;J. Timm

  • Influenza A Virus NS1 Protein Activates the PI3K/Akt Pathway To Mediate Antiapoptotic Signaling Responses

    Christina Ehrhardt;Thorsten Wolff;Stephan Pleschka;Oliver Planz

  • Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics.

    Ralf Wagner;Thorsten Wolff;Astrid Herwig;Stephan Pleschka

  • IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein.

    Bastian Opitz;Amira Rejaibi;Bianca Dauber;Jamina Eckhard

  • Influenza A Virus Inhibits Type I IFN Signaling via NF-κB-Dependent Induction of SOCS-3 Expression

    Eva-K. Pauli;Mirco Schmolke;Thorsten Wolff;Dorothee Viemann

  • NF-κB-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas/FasL Is Crucial for Efficient Influenza Virus Propagation

    Walter J. Wurzer;Christina Ehrhardt;Stephan Pleschka;Friederike Berberich-Siebelt

  • NS1 Protein of Influenza A Virus Down-Regulates Apoptosis

    O. P. Zhirnov;T. E. Konakova;T. Wolff;H.-D. Klenk

  • Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence.

    Christina Ehrhardt;Henju Marjuki;Thorsten Wolff;Bernd Nürnberg

  • Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells

    Stephan Ludwig;Stephan Pleschka;Oliver Planz;Thorsten Wolff

  • The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors

    Stephan Ludwig;Xiuyan Wang;Christina Ehrhardt;Hongyong Zheng

  • Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia

    Katrin Högner;Thorsten Wolff;Stephan Pleschka;Stephanie Plog

  • Influenza A Viruses Target Type II Pneumocytes in the Human Lung

    Viola K. Weinheimer;Anne Becher;Mario Tönnies;Gudrun Holland

  • Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappa B-inhibiting activity

    Igor Mazur;Walter J. Wurzer;Christina Ehrhardt;Stephan Pleschka

  • Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.

    Erik Alm;Eeva K Broberg;Thomas Connor;Emma B Hodcroft

  • Influenza-virus-induced signaling cascades: targets for antiviral therapy?

    Stephan Ludwig;Oliver Planz;Stephan Pleschka;Thorsten Wolff

  • Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012.

    Udo Buchholz;Marcel A. Müller;Andreas Nitsche;A. Sanewski

  • Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2

    Áine O'Toole;Verity Hill;Oliver G. Pybus;Alexander Watts

  • Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch.

    Áine O'Toole;Verity Hill;Oliver G. Pybus;Alexander Watts

Frequent Co-Authors

Stephan Ludwig
Stephan Ludwig University of Münster
Stephan Pleschka
Stephan Pleschka University of Giessen
Oliver Planz
Oliver Planz University of Tübingen
Stefan Hippenstiel
Stefan Hippenstiel Charité - University Medicine Berlin
Norbert Suttorp
Norbert Suttorp Charité - University Medicine Berlin
Andreas C. Hocke
Andreas C. Hocke Charité - University Medicine Berlin
Achim D. Gruber
Achim D. Gruber Freie Universität Berlin
Andreas Herrmann
Andreas Herrmann Humboldt-Universität zu Berlin
Susanne Herold
Susanne Herold University of Giessen
Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to various advanced healthcare roles, including specialized nursing positions that integrate immunology knowledge. Many professionals interested in immunology-related clinical work pursue advanced practice nursing degrees. For those looking to enhance their qualifications, exploring pmhnp programs online with best clinical placement can provide valuable insights into programs that blend theory with practical experience.

Affordability is a key consideration when choosing a program. Students aiming for roles such as Psychiatric Nurse Practitioner should investigate the cheapest psychiatric nurse practitioner programs to find quality education without financial strain. This is especially important as the demand for specialized nurse practitioners grows alongside advances in immunotherapy and related treatments.

Career pathways in this field often lead to lucrative positions. Understanding dnp salary by specialty helps prospective students and professionals gauge long-term earnings and choose specialties aligned with their goals and interests.

For nurses looking to pivot within specialties, bridge programs are valuable. Programs like the fnp to acnp bridge program online offer flexible pathways to transition from Family Nurse Practitioner to Acute Care Nurse Practitioner roles—relevant for those interested in acute immunology cases and critical care environments.

Best Scientists Citing Thorsten Wolff

Trending Scientists

Recently Published Articles